Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078481 | SCV000110337 | benign | not specified | 2013-02-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000767035 | SCV000492076 | uncertain significance | not provided | 2024-08-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25764212, 25989649, 35892469) |
Counsyl | RCV000674624 | SCV000799993 | uncertain significance | Niemann-Pick disease, type C1 | 2018-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000674624 | SCV001005724 | benign | Niemann-Pick disease, type C1 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000674624 | SCV001283366 | benign | Niemann-Pick disease, type C1 | 2017-10-17 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Revvity Omics, |
RCV000674624 | SCV003816043 | uncertain significance | Niemann-Pick disease, type C1 | 2021-03-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000767035 | SCV004140856 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | NPC1: BP4 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000078481 | SCV004813540 | likely benign | not specified | 2024-02-09 | criteria provided, single submitter | clinical testing | Variant summary: NPC1 c.3343G>T (p.Val1115Phe) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00069 in 251462 control chromosomes, predominantly at a frequency of 0.0099 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 3.6 fold of the estimated maximal expected allele frequency for a pathogenic variant in NPC1 causing Niemann-Pick Disease Type C phenotype (0.0027), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.3343G>T has been reported in the literature in individuals affected with Niemann-Pick Disease Type C without strong evidence of causality (Rodriguez_2015, Kubaski_2022). These reports do not provide unequivocal conclusions about association of the variant with Niemann-Pick Disease Type C. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25989649, 35892469). ClinVar contains an entry for this variant (Variation ID: 92712). Based on the evidence outlined above, the variant was classified as likely benign. |
Mayo Clinic Laboratories, |
RCV000767035 | SCV005408592 | uncertain significance | not provided | 2023-06-22 | criteria provided, single submitter | clinical testing | BA1 |
Genome Diagnostics Laboratory, |
RCV000767035 | SCV001807285 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000767035 | SCV001964769 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003935016 | SCV004755183 | likely benign | NPC1-related disorder | 2021-04-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |